ChemicalBook > CAS DataBase List > GDC-0879

GDC-0879

Product Name
GDC-0879
CAS No.
905281-76-7
Chemical Name
GDC-0879
Synonyms
CS-187;GDC-0879;GDC 0849;AR-00341677;GDC0879;GDC 0879;GDC-0879 >=98% (HPLC);GDC-0879 ISO 9001:2015 REACH;2-[4-[(1E)-1-hydroxyimino-2,3-dihydroinden-5-yl]-3-pyridin-4-ylpyrazol-1-yl]ethanol;2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime;(E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime
CBNumber
CB12473919
Molecular Formula
C19H18N4O2
Formula Weight
334.37
MOL File
905281-76-7.mol
More
Less

GDC-0879 Property

Density 
1.37
storage temp. 
Store at -20°C
solubility 
insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL in DMSO
form 
solid
Stability:
Hygroscopic
More
Less

Safety

HS Code 
2933399990
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML1953
Product name
GDC-0879
Purity
≥98% (HPLC)
Packaging
5MG
Price
$131
Updated
2024/03/01
Sigma-Aldrich
Product number
SML1953
Product name
GDC-0879
Purity
≥98% (HPLC)
Packaging
25MG
Price
$530
Updated
2024/03/01
Cayman Chemical
Product number
16993
Product name
GDC 0879
Purity
≥95%
Packaging
1mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
16993
Product name
GDC 0879
Purity
≥95%
Packaging
5mg
Price
$116
Updated
2024/03/01
Cayman Chemical
Product number
16993
Product name
GDC 0879
Purity
≥95%
Packaging
10mg
Price
$199
Updated
2024/03/01
More
Less

GDC-0879 Chemical Properties,Usage,Production

Uses

GDC 0879 is a potent B-Raf inhibitor.

Definition

ChEBI: GDC-0879 is a member of the class of pyrazoles that is 1-(2-hydroxyethyl)pyrazole carrying additional 4-pyridyl and 1-(hydroxyimino)indan-5-yl substituents at positions 3 and 4 respectively. It has a role as a B-Raf inhibitor and an antineoplastic agent. It is a member of pyrazoles, a member of pyridines, a member of indanes, a ketoxime and a primary alcohol.

Biological Activity

gdc-0879 is synthsized as a potent and selective b-raf inhibitor. the raf/mitogen-activated protein kinase kinase (mek)/extracellular signal-regulated kinase signaling pathway is reported to be involved in cellular responses, which is relevant to tumorigenesis.

in vitro

gdc-0879 is a b-raf inhibitor against various in vitro and cell-based assays, such as a375 melanoma and colo205 colorectal carcinoma cell lines, both of which are v600e b-raf mutant. when screened against a panel of 140 kinases at its efficaciou dose, gdc-0879 showed expected activity only against c-raf [1].

in vivo

in mice treated by gdc-0879, both cell line-and patient-derived brafv600e tumors exhibited stronger and more sustained pharmacodynamic inhibition (>90% for 8 hours) and improved survival compared with mutant kras-expressing tumors. moreover, it was found that the responsiveness of brafv600e melanoma cells to gdc-0879 could be dramatically altered by pharmacologic and genetic modulation of phosphatidylinositol 3-kinase pathway activity [2].

IC 50

0.13 nm against purified b-raf v600e enzyme; a cellular perk ic50 of 63 nm in the malme-3m cell line

storage

Store at -20°C

References

[1] wong h, belvin m, herter s, hoeflich kp, murray lj, wong l, choo ef. pharmacodynamics of 2-[4-[(1e)-1-(hydroxyimino)-2,3-dihydro-1h-inden-5-yl]-3-(pyridine-4-yl)-1h-pyrazol-1-yl]ethan-1-ol (gdc-0879), a potent and selective b-raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy. j pharmacol exp ther. 2009 apr;329(1):360-7.
[2] hoeflich kp, herter s, tien j, wong l, berry l, chan j, o'brien c, modrusan z, seshagiri s, lackner m, stern h, choo e, murray l, friedman ls, belvin m. antitumor efficacy of the novel raf inhibitor gdc-0879 is predicted by brafv600e mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression. cancer res. 2009 apr 1;69(7):3042-51.

GDC-0879 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GDC-0879 Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2923
Advantage
55
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
94838
Advantage
76
Chembest Research Laboratories Limited
Tel
021-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6011
Advantage
61
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Fax
0086-571-85864795
Email
sales@capotchem.com
Country
China
ProdList
18217
Advantage
66
VDM Biochemicals
Tel
0330-2528181
Fax
0330-2528171
Email
sales@vdmbio.com
Country
United States
ProdList
510
Advantage
64
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Fax
+86 (531) 55696010 QQ 1762738062
Email
sales@trio-pharmatech.com (International market)
Country
China
ProdList
1856
Advantage
62
Beijing Taiya Jie Technology Development Co., Ltd.
Tel
021-33690831-8001 13552411790
Fax
021-33690831
Email
postmaster@tyjchem.cn
Country
China
ProdList
1542
Advantage
55
Shanghai civi chemical technology co.,Ltd
Tel
86-21-34053660
Fax
86-21-34053661
Email
sale@labgogo.com
Country
China
ProdList
9872
Advantage
52
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1494
Advantage
55
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Fax
+86 21 50676805
Country
China
ProdList
9901
Advantage
58
More
Less

View Lastest Price from GDC-0879 manufacturers

Shaanxi Dideu Medichem Co. Ltd
Product
GDC-0879 905281-76-7
Price
US $1.10/g
Min. Order
1g
Purity
99.0% min
Supply Ability
100 tons min
Release date
2021-05-08
Career Henan Chemical Co
Product
GDC-0879 905281-76-7
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
100kg
Release date
2018-12-23

905281-76-7, GDC-0879Related Search:


  • GDC-0879
  • (E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime,GDC-0879
  • 2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime
  • 1H-Inden-1-one, 2,3-dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-, oxiMe
  • GDC 0849
  • (E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime
  • 2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro -1H-inden-5-yl]-3-pyridin-4-yl-1H-pyrazol-1-yl} ethanol
  • (Z)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime
  • (E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
  • 2-[4-[(1E)-1-hydroxyimino-2,3-dihydroinden-5-yl]-3-pyridin-4-ylpyrazol-1-yl]ethanol
  • (E)-2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime
  • GDC0879;GDC 0879
  • CS-187
  • AR-00341677
  • GDC-0879 >=98% (HPLC)
  • GDC-0879 ISO 9001:2015 REACH
  • 905281-76-7
  • MAPK
  • Inhibitors
  • Selective inhibitor of protein kinase.